Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Month of birth and the incidence of multiple sclerosis in southern iran.
Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury.
Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis.
DAB389IL-2 suppresses autoimmune inflammation in the CNS and inhibits T cell-mediated lysis of glial target cells.
Myelin damage due to local quantitative abnormalities in normal prion levels: evidence from subacute combined degeneration and multiple sclerosis.
IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses.
The magnetic resonance imaging appearance of monophasic acute disseminated encephalomyelitis: an update post application of the 2007 consensus criteria.
Development of [(3)H]2-Carboxy-4,6-dichloro-1H-indole-3-propionic Acid ([(3)H]PSB-12150): A Useful Tool for Studying GPR17.
Effects of vaccination with altered Peptide ligand on chronic pain in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.
Antibodies identified by cell-based assays in myasthenia gravis and associated diseases.
Advances of Molecular Imaging for Monitoring the Anatomical and Functional Architecture of the Olfactory System.
Cholesterol in myelin biogenesis and hypomyelinating disorders.
Thalamus volume and ambulation in multiple sclerosis: a cross-sectional study.
Successful treatment of neuromyelitis optica spectrum disorder by early initiation of plasma exchange.
Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant.
Multiple sclerosis and cancer: When two wrongs make a right?
What Do Effective Treatments for Multiple Sclerosis Tell Us about the Molecular Mechanisms Involved in Pathogenesis?
Multiple sclerosis: Regenerative therapies for MS-hope on the horizon.
Assessing dalfampridine efficacy in the physician's office.
Multiple sclerosis: Reactivation of Epstein-Barr or herpes viruses not associated with MS relapse.
Combined visual and motor evoked potentials predict multiple sclerosis disability after 20 years.
Supine and upright urodynamic evaluation of incontinent ileovesicostomy in wheelchair-bound adults with neurogenic bladder.
RNA processing-associated molecular mechanisms of neurodegenerative diseases.
Current topics in therapeutic plasmapheresis.
Effects of whole-body vibration training on physical function in patients with Multiple Sclerosis.
Pages
« first
‹ previous
…
537
538
539
540
541
542
543
544
545
…
next ›
last »